NLRP3 inflammasome: A promising therapeutic target for drug-induced toxicity
S Wei, W Ma, B Zhang, W Li - Frontiers in Cell and Developmental …, 2021 - frontiersin.org
Drug-induced toxicity, which impairs human organ function, is a serious problem during drug
development that hinders the clinical use of many marketed drugs, and the underlying …
development that hinders the clinical use of many marketed drugs, and the underlying …
Severe cutaneous adverse reactions
SI Hung, M Mockenhaupt, KG Blumenthal… - Nature Reviews …, 2024 - nature.com
Severe cutaneous adverse reactions (SCARs), which include Stevens–Johnson syndrome
and toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (also …
and toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (also …
Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: insights from a pan-European multicenter study
K Kridin, MC Brüggen, SL Chua, A Bygum… - JAMA …, 2021 - jamanetwork.com
Importance Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are
severe drug reactions associated with a high rate of mortality and morbidity. There is no …
severe drug reactions associated with a high rate of mortality and morbidity. There is no …
Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi‐based consensus
MC Brüggen, ST Le, S Walsh, A Toussi… - British Journal of …, 2021 - academic.oup.com
Background Supportive care is the cornerstone of management of adult and paediatric
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However …
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However …
[HTML][HTML] NSAID (nonsteroidal anti-inflammatory drugs) Induced Stevens Johnson Syndrome in a 50-year-old woman: A case study
Abstract Stevens-Johnson Syndrome (SJS) is a severe and rare adverse drug reaction
associated with significant morbidity and mortality. Although SJS is commonly triggered by …
associated with significant morbidity and mortality. Although SJS is commonly triggered by …
Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
Delayed drug T-cell immune-mediated hypersensitivity reactions have a large clinical
heterogeneity varying from mild maculopapular exanthema (MPE) to severe cutaneous …
heterogeneity varying from mild maculopapular exanthema (MPE) to severe cutaneous …
Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: diverse effects on systemic inflammation
V Schmidt, S Lalevée, S Traidl, M Ameri, R Ziadlou… - Allergy, 2023 - Wiley Online Library
Abstract Background Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis
(TEN) are rare but potentially life‐threatening cutaneous adverse reactions. There is still no …
(TEN) are rare but potentially life‐threatening cutaneous adverse reactions. There is still no …
Multidisciplinary treatment in toxic epidermal necrolysis
A Surowiecka, W Barańska-Rybak… - International Journal of …, 2023 - mdpi.com
Toxic epidermal necrolysis, Leyll's syndrome (TEN), is a rare mucocutaneous blistering
disease burdened with high mortality rates. The diagnosis of TEN is based on clinical …
disease burdened with high mortality rates. The diagnosis of TEN is based on clinical …
Stevens-Johnson syndrome and toxic epidermal necrolysis—coordinating research priorities to move the field forward
EJ Phillips, CS Bouchard, SJ Divito - JAMA dermatology, 2022 - jamanetwork.com
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is the most life-
threatening disease managed by dermatologists. Although SJS/TEN only affects 1 to 5 …
threatening disease managed by dermatologists. Although SJS/TEN only affects 1 to 5 …
Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology …
1 Has C, Bauer JW, Bodemer C et al. Consensus reclassification of inherited epidermolysis
bullosa and other disorders with skin fragility. Br J Dermatol 2020; 183: 614–27. 2 Hérissé …
bullosa and other disorders with skin fragility. Br J Dermatol 2020; 183: 614–27. 2 Hérissé …